Showing results (351-360 of 366) with videos related to
Sort By:
Pageof 37
Lancet (London, England)|February 3, 1999
Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study GroupJ S Smolen, J R Kalden, D L Scott, et al.European Journal of Medical Research|February 28, 1998
In vivo proton magnetic resonance spectroscopy in polymyositis and dermatomyositis: a preliminary studyY L Chung, E C Smith, S C Williams, et al.Rheumatology (Oxford, England)|July 11, 2000
A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritisP Emery, F C Breedveld, E M Lemmel, et al.Scandinavian Journal of Rheumatology|July 27, 2001
Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazineA Larsen, T K Kvien, M Schattenkirchner, et al.Annals of the Rheumatic Diseases|October 1, 1992
Keratan sulphate in rheumatoid arthritis, osteoarthritis, and inflammatory diseasesT D Spector, L Woodward, G M Hall, et al.European Journal of Rheumatology and Inflammation|January 1, 1992
Enteric coated naproxen; a double blind trial comparing the tolerance of enteric coated and standard formulationsE C Huskisson, R M Bernstein, J S Coppock, et al.The Journal of Rheumatology|September 12, 2001
Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study GroupJ R Kalden, D L Scott, J S Smolen, et al.Annals of the Rheumatic Diseases|September 15, 2001
Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazineD L Scott, J S Smolen, J R Kalden, et al.Arthritis and Rheumatism|August 6, 2005
Muscle metabolites, detected in urine by proton spectroscopy, correlate with disease damage in juvenile idiopathic inflammatory myopathiesY-L Chung, L G Rider, J D Bell, et al.Clinical and Experimental Rheumatology|July 10, 2002
Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodiumE H S Choy, D L Scott, G H Kingsley, et al.Pageof 37